More and more information has recently been published about "new pills" (see new pill for Celiac news article) or new cures (see articles on T-Cell research) that are being developed to combat autoimmune issues. Recently a large pharmaceutical company announced it is advancing a new monoclonal antibody, considered a validated potential target in the treatment of a range of autoimmune diseases, into a clinical trial in humans (see autoimmunefacts.info). It is encouraging to see this novel research being conducted around the world, which hopeful will result in a breakthrough treatment for autoimmune patients.
Leave a Reply
You must be logged in to post a comment.